World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT01784250
Date of registration: 23/01/2013
Prospective Registration: No
Primary sponsor: CES University
Public title: Efficacy of Clonidine and Propranolol in Dentistry (AAA)
Scientific title: Efficacy of Clonidine and Propranolol Versus Placebo for the Control of Anxiety During Surgical Procedures in Dentistry
Date of first enrolment: August 2012
Target sample size: 60
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01784250
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment  
Phase:  Phase 2
Countries of recruitment
Colombia
Contacts
Name:     Ana K Tamara, Physician
Address: 
Telephone:
Email:
Affiliation:  CES University
Name:     Patricia Bermudez, Dentistry
Address: 
Telephone:
Email: patvanss@hotmail.com
Affiliation: 
Name:     Libia M Rodriguez, Magister
Address: 
Telephone:
Email:
Affiliation:  CES University
Name:     Patricia Bermudez, Dentistry
Address: 
Telephone:
Email:
Affiliation:  CES University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Normotensive patients and pre-hypertension who are undergoing elective surgery for
removal of third molars.

- Age range 14 to 40 years

- Patients with dental anxiety above 13 points on the scale (MDAS).

- People who voluntarily agree to participate in the study and sign the informed
consent form

Exclusion Criteria:

- Patients receiving any medication for any chronic pathology.

- Patients of African American race, being more likely to have abnormal blood pressure.

- Patients with a history of cardiovascular disease.

- Patients with chronic systemic disease such as diabetes, hyper or hypothyroidism,
Addison's syndrome, renal failure, hypertension or liver disease.

- Pregnant or breastfeeding.

- Patients diagnosed with anxiety disorder or depressive disorder



Age minimum: 14 Years
Age maximum: 40 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Anxiety
Intervention(s)
Drug: Propranolol
Drug: Placebo
Drug: Clonidine
Primary Outcome(s)
Change from baseline in modified dental anxiety scale(MDAS)and vital signs (blood pressure, heart rate, respiratory rate, oxygen saturation) until four hours post treatment [Time Frame: (plus or minus 4 hours) after surgery]
Secondary Outcome(s)
Changes in Verbal Numerical Rating Scale (VNRS) at three, six, and twenty-four hours post treatment [Time Frame: 24 hours]
Secondary ID(s)
CLON000
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history